...
首页> 外文期刊>Pain Physician >Analgesic Effect of Nalbuphine When Added to Intravenous Regional Anesthesia: A Randomized Control Trial
【24h】

Analgesic Effect of Nalbuphine When Added to Intravenous Regional Anesthesia: A Randomized Control Trial

机译:盐酸纳布啡的镇痛作用:静脉区域麻醉:随机对照试验

获取原文

摘要

Different adjuvant drugs are currently added to lidocaine for intravenous regional anesthesia (IVRA) to decrease tourniquet and postoperative pain.OBJECTIVE: The aim of the study was to examine the effect of nalbuphine when added toIVRA.STUDY DESIGN: Prospective, randomized, double-blind, controlled clinical trial.SETTING: Assiut University Hospitals.METHODS: One hundred-six adult patients scheduled for unilateral hand surgery under IVRA were randomized into 2 equal groups. The lidocaine-nalbuphine (LN) group received nalbuphine plus lidocaine and the lidocaine (L) group received lidocaine. A tourniquet and postoperative pain were assessed using a visual analogue scale (VAS). The following parameters were measured: onset and recovery time for both sensory and motor blocks, intra- and postoperative analgesic consumption, time to first analgesic request, postoperative nausea and/or vomiting (PONV), hemodynamics, and cortisol levels.RESULTS: Early tourniquet and postoperative pain were significantly lower in the LN group. The onset time for both sensory and motor blocks was significantly shorter in the LN group. In addition, the recovery time for both sensory and motor blocks was longer in the LN group. Intra- and postoperative fentanyl consumption was significantly lower in the LN group with no significance in postoperative diclofenac consumption. The patient first analgesic request was significantly delayed in the LN group (P < 0.0001). There were no significant differences between the 2 groups in PONV, hemodynamic parameters abnormalities, medications adverse events or cortisol levels.LIMITATIONS: The inclusion of a study group in which the nalbuphine administered systemically could determine whether its beneficial effects were due to its local or systemic action.CONCLUSIONS: Nalbuphine decreases early tourniquet and postoperative pain after IVRA and delays the need for analgesic rescue. In addition, nalbuphine accelerates the onset and prolongs the recovery time for both sensory and motor blocks with no significant adverse events. However, it has no effect on postoperative cortisol levels.Key words: Intravenous, regional anesthesia, lidocaine, nalbuphine, pain, postoperative
机译:利多卡因目前正在为静脉局部麻醉(IVRA)添加不同的辅助药物,以减轻止血带和术后疼痛。目的:本研究的目的是研究将纳布啡加入IVRA的效果。研究设计:前瞻性,随机,双盲,通过对照的临床试验进行。地点:阿瑟特大学医院。方法:将106名接受IVRA单侧手部手术的成年患者随机分为两组。利多卡因-纳布啡(LN)组接受纳布啡加利多卡因,利多卡因(L)组接受利多卡因。使用视觉模拟量表(VAS)评估止血带和术后疼痛。测量以下参数:感觉和运动阻滞的发作和恢复时间,术中和术后止痛药的消耗,首次止痛的时间,术后恶心和/或呕吐(PONV),血液动力学和皮质醇水平。结果:早期止血带LN组的术后疼痛明显降低。 LN组的感觉障碍和运动障碍的发作时间明显缩短。此外,LN组的感觉障碍和运动障碍的恢复时间更长。 LN组术中和术后的芬太尼消耗量显着降低,对术后双氯芬酸的消耗量无影响。 LN组患者的首次镇痛要求明显延迟(P <0.0001)。两组之间在PONV,血流动力学参数异常,药物不良事件或皮质醇水平方面无显着差异。局限性:纳入一个研究组可以全身性地使用纳布啡,可以确定其有益作用是由于其局部还是全身性结论:纳布啡减少了IVRA后的早期止血带和术后疼痛,并延迟了止痛药的需要。此外,纳布啡可加速发作并延长感觉障碍和运动障碍的恢复时间,而无明显不良事件。然而,它对术后皮质醇水平没有影响。关键词:静脉内,区域麻醉,利多卡因,纳布啡,疼痛,术后

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号